Cerus Corporation
- CERS
- NASDAQ
- Medical devices
- Blood Safety Technology
- Pathogen Reduction
$2.18
Today −3.54%Quote Oct 16, 2026, 08:00 PM UTC
−18.05%over the last month
Max drawdown −18.4%From 1-month high −18.4%3 months −30.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$439.3M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$4.00
+83.5% from here
Floor
$2.09
4.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CERSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
268